Evidence map›Paper›PMID 20942470›Full record

ArticleJournal of medicinal chemistry2010

Nicotinic acid adenine dinucleotide phosphate analogues containing substituted nicotinic acid: effect of modification on Ca(2+) release.

Pooja Jain, James T Slama, Leroy A Perez-Haddock, Timothy F Walseth

Open access · greenAbstract read
In one paragraph

Article in Journal of medicinal chemistry, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.9field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. NAADP-Evoked CaHandbook of experimental pharmacology · 2023
    Article
  4. Article
  5. Article
  6. NAADP: From Discovery to Mechanism.Frontiers in immunology · 2021
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. The Molecular Basis for CaMessenger (Los Angeles, Calif. : Print) · 2012
    Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Pooja JainDepartment of Medicinal and Biological Chemistry, College of Pharmacy, University of Toledo, Health Science Campus, MS no 1015, 3000 Arlington Avenue, Toledo, Ohio 43614, USA.
James T Slama
Leroy A Perez-Haddock
Timothy F Walseth
University of Minnesota Medical Center · USUniversity of Toledo · US

Funding

Subcellular Targeting/Packaging of Opioids/ReceptorsP50DA011806 · NIDA · UNIVERSITY OF MINNESOTA TWIN CITIES · PI LOH, HORACE · 1998 to 2012
$14.0M
Summer Research Training at the University of Minnesota Medical SchoolR25HL088728 · NHLBI · UNIVERSITY OF MINNESOTA · PI COLIN R CAMPBELL, Dang Hai Nguyen · 2007 to 2026
$2.9M
NHLBI NIH HHS R25 HL088728NIDA NIH HHS DA11806NIDA NIH HHS P50 DA011806
6 · The paper itself

Abstract

Analogues of nicotinic acid adenine dinucleotide phosphate (NAADP) with substitution at either the 4- or the 5-position position of the nicotinic acid moiety have been synthesized from NADP enzymatically using Aplysia californica ADP-ribosyl cyclase or mammalian NAD glycohydrolase. Substitution at the 4-position of the nicotinic acid resulted in the loss of agonist potency for release of Ca(2+)-ions from sea urchin egg homogenates and in potency for competition ligand binding assays using [(32)P]NAADP. In contrast, several 5-substituted NAADP derivatives showed high potency for binding and full agonist activity for Ca(2+) release. 5-Azido-NAADP was shown to release calcium from sea urchin egg homogenates at low concentration and to compete with [(32)P]NAADP in a competition ligand binding assay with an IC(50) of 18 nM, indicating that this compound might be a potential photoprobe useful for specific labeling and identification of the NAADP receptor.

Indexed as

ADP-ribosyl CyclaseAnimalsAplysiaBinding, CompetitiveCalciumCalcium Channel AgonistsCalcium Channel BlockersCalcium ChannelsIn Vitro TechniquesNAD+ NucleosidaseNADPNiacinRadioligand AssaySea UrchinsStructure-Activity RelationshipADP-ribosyl CyclaseCalciumCalcium Channel AgonistsCalcium Channel BlockersCalcium ChannelsNAADPNAD+ NucleosidaseNADPNiacin

Identifiers

PMID20942470
PMCPMC3060082
OpenAlexW2049611644

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.